Treating Breast Cancer with Metformin episode artwork

EPISODE · Jul 18, 2022 · 22 MIN

Treating Breast Cancer with Metformin

from CEimpact Podcast · host CEimpact

Several large observational studies have suggested metformin has anti-tumor effects and may be beneficial as an adjunctive treatment option for breast cancer. This hypothesis was tested by a randomized clinical trial recently published. Listen to host Geoff Wall discuss if metformin is a miracle drug. The GameChanger Metformin can alter insulin signaling which is crucial for the development of certain types of cancer cells. Thus, in various observational and pre-clinical studies, metformin has been associated with better outcomes in breast cancer, usually in patients with diabetes. A recently published RCT found no benefit of taking adjunctive metformin in patients with breast cancer and no diabetes.  Show Segments 00:00 – Introductions 01:19 – Metformin in the Treatment of Breast Cancer 02:21 – Insulin Signaling in Tumor Cell Development  06:54 – Effect of Metformin Vs Placebo on Invasive Disease-Free Survival in Patients with Breast Cancer: The MA.32 Randomized Clinical Trial 17:09 – Connecting to Practice & Further Studies  21:17 – The GameChanger 21:55 – Closing Remarks Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health References and Resources Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial Redeem your CPE or CME here CPE (Pharmacist)  CME (Physician)   Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a membership Prescribers: Get a membership  CE Information Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: Describe the potential mechanism(s) of action of metformin as an anti-tumor agent Discuss the MA.32 study and role of metformin in breast cancer treatment  0.05 CEU/0.5 Hr UAN: 0107-0000-22-248-H01-P Initial release date: 7/18/22 Expiration date: 7/18/23 Additional CPE and CME details can be found here.   Follow CEimpact on Social Media:LinkedInInstagram

Episode metadata supplied by the publisher feed · Published Jul 18, 2022

Embed this episode

Several large observational studies have suggested metformin has anti-tumor effects and may be beneficial as an adjunctive treatment option for breast cancer. This hypothesis was tested by a randomized clinical trial recently published. Listen to host Geoff Wall discuss if metformin is a miracle drug. The GameChanger Metformin can alter insulin signaling which is crucial for the development of certain types of cancer cells. Thus, in various observational and pre-clinical studies...

Distinct summary based on available episode metadata or transcript content.

Ready to play

Treating Breast Cancer with Metformin

0:00 22:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of CEimpact Podcast?

This episode is 22 minutes long.

When was this CEimpact Podcast episode published?

This episode was published on July 18, 2022.

Can I download this CEimpact Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!